About this trial
The study will include women who present to the Obstetrics and Gynecology outpatient clinic of Kırşehir Ahi Evran Training and Research Hospital with complaints of pelvic pain and are diagnosed with PCAS after a detailed examination, as well as healthy women. All included women will be administered the Tampa Kinesiophobia Scale (TKS), the International Physical Activity Questionnaire (Short), the Pittsburgh Sleep Quality Questionnaire (PSQI), and the Short Form 36 (p-36). The control group will consist of women who meet the inclusion and exclusion criteria but are not diagnosed with PCAS.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Being between 18-65 years of age
Having a diagnosis of Chronic Pelvic Pain
Having a pain score of 5 or higher on the visual analog scale
Voluntary participation in the study
Disqualifiers
Not wanting to continue in the study
Presence of neurological or orthopedic disease
Active urinary tract infection or recurrent urinary tract infection (more than 5 recurrent infections in the last 12 months)
Pregnancy
Trial population
women with chronic pelvic pain
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
questionnaire
Other interventionevaluation
Treatment groups
Trial outcomes
Primary outcomes
kinesiophobia
Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia (TSK). The scale consists of 17 items rated on a 4-point Likert scale. The total score ranges from 17 to 68, with higher scores indicating greater levels of kinesiophobia.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.